BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23170994)

  • 1. Peptido sulfonyl fluorides as new powerful proteasome inhibitors.
    Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM
    J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides.
    Brouwer AJ; Herrero Álvarez N; Ciaffoni A; van de Langemheen H; Liskamp RM
    Bioorg Med Chem; 2016 Aug; 24(16):3429-35. PubMed ID: 27316540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
    Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
    J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential peptidic proteasome inhibitors by incorporation of an electrophilic trap based on amino acid derived α-substituted sulfonyl fluorides.
    Herrero Alvarez N; van de Langemheen H; Brouwer AJ; Liskamp RMJ
    Bioorg Med Chem; 2017 Oct; 25(19):5055-5063. PubMed ID: 28734665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudopeptides with aldehyde or vinylsulfone warheads: Synthesis and antiproteasomal activity.
    Jorda R; Molitorová V; Pilařová E; Vojáčková V; Řezníčková E; Svobodová K; Pauk K; Imramovský A; Kryštof V
    Bioorg Chem; 2021 Oct; 115():105228. PubMed ID: 34371374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors.
    Verdoes M; Florea BI; van der Linden WA; Renou D; van den Nieuwendijk AM; van der Marel GA; Overkleeft HS
    Org Biomol Chem; 2007 May; 5(9):1416-26. PubMed ID: 17464411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors.
    Franceschini C; Trapella C; Calia R; Scotti A; Sforza F; Gavioli R; Marastoni M
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1034-9. PubMed ID: 22871133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides.
    Artschwager R; Ward DJ; Gannon S; Brouwer AJ; van de Langemheen H; Kowalski H; Liskamp RMJ
    J Med Chem; 2018 Jun; 61(12):5395-5411. PubMed ID: 29782167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of peptidomimetic boronates as proteasome inhibitors.
    Micale N; Ettari R; Lavecchia A; Di Giovanni C; Scarbaci K; Troiano V; Grasso S; Novellino E; Schirmeister T; Zappalà M
    Eur J Med Chem; 2013 Jun; 64():23-34. PubMed ID: 23639651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
    Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
    J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action.
    Kawamura S; Unno Y; List A; Mizuno A; Tanaka M; Sasaki T; Arisawa M; Asai A; Groll M; Shuto S
    J Med Chem; 2013 May; 56(9):3689-700. PubMed ID: 23547757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolo-phakellins as β5-specific noncovalent proteasome inhibitors.
    Beck P; Lansdell TA; Hewlett NM; Tepe JJ; Groll M
    Angew Chem Int Ed Engl; 2015 Feb; 54(9):2830-3. PubMed ID: 25581903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα- and αβ-amino acids.
    Shi J; Lei M; Wu W; Feng H; Wang J; Chen S; Zhu Y; Hu S; Liu Z; Jiang C
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1958-62. PubMed ID: 26965867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
    Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
    Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the 26S proteasome by peptide mimics of the coiled-coil region of its ATPase subunits.
    Inobe T; Genmei R
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):143-50. PubMed ID: 26522225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i).
    Klein M; Busch M; Friese-Hamim M; Crosignani S; Fuchss T; Musil D; Rohdich F; Sanderson MP; Seenisamy J; Walter-Bausch G; Zanelli U; Hewitt P; Esdar C; Schadt O
    J Med Chem; 2021 Jul; 64(14):10230-10245. PubMed ID: 34228444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a potent and highly specific β
    Zhou T; Cai Y; Liang L; Yang L; Xu F; Niu Y; Wang C; Zhang JL; Xu P
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5780-5784. PubMed ID: 27816516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development.
    Huber EM; Groll M
    Angew Chem Int Ed Engl; 2012 Aug; 51(35):8708-20. PubMed ID: 22711561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits.
    Hovhannisyan AA; Pham TH; Bouvier D; Tan X; Touhar S; Mkryan GG; Dallakyan AM; El Amri C; Melikyan GS; Reboud-Ravaux M; Bouvier-Durand M
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5172-5178. PubMed ID: 29113763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational inhibition studies of the human proteasome by argyrin-based analogues with subunit specificity.
    Loizidou EZ; Zeinalipour-Yazdi CD
    Chem Biol Drug Des; 2014 Jul; 84(1):99-107. PubMed ID: 24521156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.